1
|
Diesel LP, de Mello LS, de Oliveira Santana W, Ikuta N, Fonseca ASK, Kipper D, Redaelli R, Pereira VRZB, Streck AF, Lunge VR. Epidemiological Insights into Feline Leukemia Virus Infections in an Urban Cat ( Felis catus) Population from Brazil. Animals (Basel) 2024; 14:1051. [PMID: 38612290 PMCID: PMC11010845 DOI: 10.3390/ani14071051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2024] [Revised: 03/17/2024] [Accepted: 03/27/2024] [Indexed: 04/14/2024] Open
Abstract
Feline leukemia virus (FeLV) is a retrovirus distributed worldwide in domestic cats and with different outcomes (progressive, regressive, abortive, focal). The present study reports an epidemiological survey of FeLV frequency and the evaluation of some risk factors and the two main disease outcomes (progressive and regressive) in an urban cat population from Brazil. A total of 366 cats with sociodemographic information and p27 FeLV antigen test performed were included in the study. FeLV DNA (provirus) in the blood samples of all cats was detected via real-time polymerase chain reaction (qPCR). Plasma samples from 109 FeLV-positive and FeLV-negative cats were also submitted to reverse transcription (RT-qPCR) to determine the FeLV viral load. The results demonstrated that 112 (30.6%) cats were positive through the p27 antigen and/or qPCR. A risk factor analysis demonstrated that cats without vaccination against FeLV (OR 9.9, p < 0.001), clinically ill (OR 2.9, p < 0.001), with outdoors access (OR 2.7, p < 0.001), and exhibiting apathetic behavior (OR 3.1, p < 0.001) were more likely to be infected with FeLV. FeLV-infected cats were also more likely to present with anemia (OR 13, p < 0.001) and lymphoma (OR 13.7, p = 0.001). A comparative analysis of the different detection methods in a subset of 109 animals confirmed FeLV infection in 58 cats, including 38 (65.5%) with progressive, 16 (27.6%) with regressive, and 4 (6.9%) with probably focal outcome diseases. In conclusion, this study demonstrates a high prevalence of FeLV in this urban cat population from Brazil and highlights the need to establish more effective prevention strategies (such as viral testing, vaccination programs, specific care for FeLV-positive cats) to reduce diseases associated with this virus in Brazil.
Collapse
Affiliation(s)
- Laura Pancich Diesel
- Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul 95070-560, RS, Brazil; (L.P.D.); (W.d.O.S.); (V.R.Z.B.P.); (A.F.S.)
| | - Lauren Santos de Mello
- Simbios Biotechnologia, Cachoeirinha 94950-000, RS, Brazil; (L.S.d.M.); (N.I.); (A.S.K.F.); (D.K.)
| | - Weslei de Oliveira Santana
- Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul 95070-560, RS, Brazil; (L.P.D.); (W.d.O.S.); (V.R.Z.B.P.); (A.F.S.)
| | - Nilo Ikuta
- Simbios Biotechnologia, Cachoeirinha 94950-000, RS, Brazil; (L.S.d.M.); (N.I.); (A.S.K.F.); (D.K.)
| | | | - Diéssy Kipper
- Simbios Biotechnologia, Cachoeirinha 94950-000, RS, Brazil; (L.S.d.M.); (N.I.); (A.S.K.F.); (D.K.)
| | - Raquel Redaelli
- Gatices Veterinary Hospital, Caxias do Sul 95000-000, RS, Brazil;
| | - Vagner Reinaldo Zingali Bueno Pereira
- Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul 95070-560, RS, Brazil; (L.P.D.); (W.d.O.S.); (V.R.Z.B.P.); (A.F.S.)
| | - André Felipe Streck
- Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul 95070-560, RS, Brazil; (L.P.D.); (W.d.O.S.); (V.R.Z.B.P.); (A.F.S.)
| | - Vagner Ricardo Lunge
- Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul 95070-560, RS, Brazil; (L.P.D.); (W.d.O.S.); (V.R.Z.B.P.); (A.F.S.)
- Simbios Biotechnologia, Cachoeirinha 94950-000, RS, Brazil; (L.S.d.M.); (N.I.); (A.S.K.F.); (D.K.)
| |
Collapse
|
2
|
Nájera F, López G, Del Rey-Wamba T, Malik RA, Garrote G, López-Parra M, Fernández-Pena L, García-Tardío M, Arenas-Rojas R, Simón MA, Zorrilla I, Fernández I, Alcaide EM, Ruiz C, Revuelta L, Salcedo J, Hofmann-Lehmann R, Meli ML. Long-term surveillance of the feline leukemia virus in the endangered Iberian lynx (Lynx pardinus) in Andalusia, Spain (2008-2021). Sci Rep 2024; 14:5462. [PMID: 38443503 PMCID: PMC10914683 DOI: 10.1038/s41598-024-55847-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 02/28/2024] [Indexed: 03/07/2024] Open
Abstract
Feline leukemia virus (FeLV) infection is considered one of the most serious disease threats for the endangered Iberian lynx (Lynx pardinus) Over 14 years (2008-2021), we investigated FeLV infection using point-of-care antigen test and quantitative real-time TaqMan qPCR for provirus detection in blood and tissues in lynxes from Andalusia (Southern Spain). A total of 776 samples from 586 individuals were included in this study. The overall prevalence for FeLV antigen in blood/serum samples was 1.4% (5/360) (95% CI: 0.2-2.6), FeLV proviral DNA prevalence in blood samples was 6.2% (31/503) (95% CI: 4.1-8.6), and FeLV proviral DNA in tissues samples was 10.2% (34/333) (95% CI: 7-13.5). From a subset of 129 longitudinally sampled individuals, 9.3% (12/129) PCR-converted during the study period. Our results suggest that FeLV infection in the Andalusian population is enzootic, with circulation of the virus at low levels in almost all the sampling years. Moreover, since only one viremic individual succumbed to the infection, this study suggests that lynxes may therefore control the infection decreasing the possibility of developing a more aggressive outcome. Although our results indicate that the FeLV infection in the Iberian lynx from Andalusia tends to stay within the regressive stage, continuous FeLV surveillance is paramount to predict potential outbreaks and ensure the survival of this population.
Collapse
Affiliation(s)
- Fernando Nájera
- Wildlife Health Center, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
- Department of Animal Physiology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040, Madrid, Spain.
- Asistencia Técnica de la Dirección General del Medio Natural y Desarrollo Sostenible de la Junta de Comunidades de Castilla-La Mancha, Plaza del Cardenal Siliceo s/n, 45071, Toledo, Spain.
| | - Guillermo López
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain.
| | - Tere Del Rey-Wamba
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Rimsha A Malik
- Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, 08544, USA
- College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA
| | - Germán Garrote
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Marcos López-Parra
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Leonardo Fernández-Pena
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Maribel García-Tardío
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Rafael Arenas-Rojas
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Miguel A Simón
- Consejería de Sostenibilidad, Medio Ambiente y Economía Azul, avda. Manuel Siurot, nº 50, 41013, Seville, Spain
| | - Irene Zorrilla
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Isabel Fernández
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Eva M Alcaide
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Carmen Ruiz
- Agencia de Medio Ambiente y Agua de Andalucía, C/ Johan G. Gutenberg 1, Isla de la Cartuja, 41092, Seville, Spain
| | - Luis Revuelta
- Department of Animal Physiology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040, Madrid, Spain
| | - Javier Salcedo
- Consejería de Sostenibilidad, Medio Ambiente y Economía Azul, avda. Manuel Siurot, nº 50, 41013, Seville, Spain
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057, Zurich, Switzerland
| | - Marina L Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057, Zurich, Switzerland
| |
Collapse
|
3
|
Choi YR, Iturriaga MP, Nekouei O, Tu T, Van Brussel K, Barrs VR, Beatty JA. Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile. Viruses 2023; 16:46. [PMID: 38257747 PMCID: PMC10820300 DOI: 10.3390/v16010046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 12/20/2023] [Accepted: 12/22/2023] [Indexed: 01/24/2024] Open
Abstract
Cat ownership is common in Chile, but data on the regional prevalence of infectious agents are limited. A sero-molecular survey of 120 client- or shelter-owned domestic cats in greater Santiago was performed. Whole blood DNA was tested for the novel hepatitis-B-like virus, domestic cat hepadnavirus (DCH) by conventional PCR (cPCR) and quantitative PCR (qPCR), and for feline leukaemia virus (FeLV) by qPCR. Point-of-care serology for FeLV p27 antigen and antibodies recognising feline immunodeficiency virus (FIV) p15 and p24 was performed. DCH DNA was detected in the serum of 2/120 cats (1.67%). Sequencing and phylogenetic analysis showed that the DCH detected in Chile occupies a position outside the main clustering of DCH in the near-complete genome tree. Progressive (antigen-positive, provirus-positive) and regressive (antigen-negative, provirus-positive) FeLV infections were identified in 6/120 (5%) and 9/120 (7.5%) of cats. A total of 2/120 (1.7%) cats had dual FeLV/FIV infection, and another 2 cats had FIV infection alone. This study shows that the global footprint of DCH includes South America with a low molecular frequency in Chile, similar to that reported in the USA. Progressive FeLV infection is relatively common in urban Chile, and male cats are at greater risk than females. Testing and control measures for pathogenic retroviruses are indicated. The potential impact of FeLV, FIV and DCH on Chile's wildcat species is worthy of further investigation.
Collapse
Affiliation(s)
- Yan Ru Choi
- Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong;
- Centre for Animal Health and Welfare, City University of Hong Kong, Hong Kong
| | - María Paz Iturriaga
- Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 7550196, Chile;
| | - Omid Nekouei
- Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life, Hong Kong;
| | - Thomas Tu
- Storr Liver Centre, Westmead Clinical School and Westmead Institute for Medical Research, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia;
- Sydney Institute for Infectious Diseases, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia
| | - Kate Van Brussel
- Department of Biology, University of Massachusetts, Boston, MA 02125, USA;
| | - Vanessa R. Barrs
- Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong;
- Centre for Animal Health and Welfare, City University of Hong Kong, Hong Kong
| | - Julia A. Beatty
- Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong;
- Centre for Animal Health and Welfare, City University of Hong Kong, Hong Kong
| |
Collapse
|
4
|
Moll GM, Swenson CL, Yuzbasiyan-Gurkan V. BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines. Viruses 2023; 15:1853. [PMID: 37766260 PMCID: PMC10535802 DOI: 10.3390/v15091853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Revised: 08/28/2023] [Accepted: 08/29/2023] [Indexed: 09/29/2023] Open
Abstract
Feline leukemia virus (FeLV) is a cosmopolitan gammaretrovirus that causes lifelong infections and fatal diseases, including leukemias, lymphomas, immunodeficiencies, and anemias, in domestic and wild felids. There is currently no definitive treatment for FeLV, and while existing vaccines reduce the prevalence of progressive infections, they neither provide sterilizing immunity nor prevent regressive infections that result in viral reservoirs with the potential for reactivation, transmission, and the development of associated clinical diseases. Previous studies of murine leukemia virus (MuLV) established that host cell epigenetic reader bromodomain and extra-terminal domain (BET) proteins facilitate MuLV replication by promoting proviral integration. Here, we provide evidence that this facilitatory effect of BET proteins extends to FeLV. Treatment with the archetypal BET protein bromodomain inhibitor (+)-JQ1 and FeLV challenge of two phenotypically disparate feline cell lines, 81C fibroblasts and 3201 lymphoma cells, significantly reduced FeLV proviral load, total FeLV DNA load, and p27 capsid protein expression at nonlethal concentrations. Moreover, significant decreases in FeLV proviral integration were documented in 81C and 3201 cells. These findings elucidate the importance of BET proteins for efficient FeLV replication, including proviral integration, and provide a potential target for treating FeLV infections.
Collapse
Affiliation(s)
- Garrick M. Moll
- Comparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA;
| | - Cheryl L. Swenson
- Comparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA;
- Department of Pathobiology & Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
| | - Vilma Yuzbasiyan-Gurkan
- Comparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA;
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
- Department of Microbiology & Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA
| |
Collapse
|
5
|
Giselbrecht J, Jähne S, Bergmann M, Meli ML, Pineroli B, Boenzli E, Teichmann-Knorrn S, Zablotski Y, Pennisi MG, Layachi N, Serra R, Bo S, Hofmann-Lehmann R, Hartmann K. Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries. Viruses 2023; 15:1718. [PMID: 37632060 PMCID: PMC10459464 DOI: 10.3390/v15081718] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 08/07/2023] [Accepted: 08/08/2023] [Indexed: 08/27/2023] Open
Abstract
Prevalence of progressive feline leukaemia virus (FeLV) infection is known to still be high in cats in Europe, especially in Southern Europe, but the prevalence of other outcomes of FeLV infection has not been determined in most countries. The present study aimed to investigate the prevalence of progressive, regressive, abortive, and focal infection in four European countries, two with a high (Italy, Portugal) and two with a low expected prevalence (Germany, France). Blood samples of 934 cats (Italy: 269; Portugal: 240; France: 107; Germany: 318) were evaluated for the p27 antigen, as well as anti-whole virus, anti-SU, and anti-p15E antibodies by enzyme-linked immunosorbent assay (ELISA) in serum and for proviral DNA by quantitative polymerase chain reaction (qPCR) in whole blood. Positive p27 antigen ELISA results were confirmed by reverse transcriptase-qPCR (RT-qPCR) detecting viral RNA in saliva swabs and/or blood. The outcome of FeLV infection was categorised as progressive (antigen-positive, provirus-positive), regressive (antigen-negative, provirus-positive), abortive (antigen- and provirus-negative, antibody-positive), and focal (antigen-positive, provirus-negative) infection. Overall FeLV prevalence was 21.2% in Italy, 20.4% in Portugal, 9.5% in Germany, and 9.3% in France. Prevalence of progressive, regressive, abortive, and focal infection in Italy was 7.8%, 4.5%, 6.3%, and 2.6%; in Portugal 3.8%, 8.3%, 6.7%, and 1.7%; in Germany 1.9%, 1.3%, 3.5%, and 2.8%; in France 1.9%, 3.7%, 2.8%, and 0.9%, respectively. In conclusion, overall FeLV prevalence is still very high, especially in Southern European countries. Therefore, testing, separation of infected cats, and vaccination are still important measures to reduce the risk of FeLV infection.
Collapse
Affiliation(s)
- Juliana Giselbrecht
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Stéphanie Jähne
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Michèle Bergmann
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Benita Pineroli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Eva Boenzli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | | | - Yury Zablotski
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | | | | | - Rodrigo Serra
- Investigacao Veterinaria Independente, 1700-119 Lisbon, Portugal;
| | - Stefano Bo
- Ambulatorio Veterinario Bo-Ferro, 10123 Turin, Italy;
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Katrin Hartmann
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| |
Collapse
|
6
|
Kornya M, Bienzle D, Beeler-Marfisi J. Discordant FeLV p27 immunoassay and PCR test results in 21 cats with hematologic disorders. J Feline Med Surg 2023; 25:1098612X231183297. [PMID: 37439634 PMCID: PMC10812061 DOI: 10.1177/1098612x231183297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/14/2023]
Abstract
CASE SERIES SUMMARY A total of 1692 medical records from a primary care feline practice and a veterinary referral hospital were evaluated retrospectively to assess discordant feline leukemia virus (FeLV) test results. In total, 73 cats were positive for FeLV using serum in a lateral flow immunoassay (LFI) or laboratory-based ELISA. Of these cats, 21 subsequently tested negative for FeLV proviral DNA by non-quantitative PCR on EDTA whole blood (16/21, 76.2%), bone marrow (4/21, 19%) or both (1/21, 4.7%). The proportional morbidity (an estimate of prevalence in a sample of the total population) for FeLV by LFI/ELISA and PCR assays was 3.1%, consistent with that reported in previous studies for cats in North America. Cats with discordant LFI/ELISA and PCR results had either primary bone marrow disease (18 autoimmune, one neoplastic), a bone marrow insult (hemotrophic mycoplasmosis) or systemic inflammation (pyothorax with a marked neutrophilic leukocytosis). The percentage of cats with a positive LFA/ELISA result and negative PCR assay surviving to discharge was 85.7% (18/21). Of these, 88.9% (16/18) survived 4 months to 6 years. Seven cats (33.3%) were re-tested with LFI or ELISA once primary disease was controlled, and all tested negative. RELEVANCE AND NOVEL INFORMATION These findings indicate that in cats with bone marrow disease that shares features of progressive FeLV infection, positive LFI and ELISA FeLV test results should be followed up with FeLV proviral DNA PCR testing, particularly in populations where disease prevalence is low.
Collapse
Affiliation(s)
- Matthew Kornya
- Department of Clinical Studies, University of Guelph, Guelph, ON, Canada
| | - Dorothee Bienzle
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| | - Janet Beeler-Marfisi
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| |
Collapse
|
7
|
Biezus G, Grima de Cristo T, da Silva Casa M, Lovatel M, Vavassori M, Brüggemann de Souza Teixeira M, Miletti LC, Maciel da Costa U, Assis Casagrande R. Progressive and regressive infection with feline leukemia virus (FeLV) in cats in southern Brazil: Prevalence, risk factors associated, clinical and hematologic alterations. Prev Vet Med 2023; 216:105945. [PMID: 37209619 DOI: 10.1016/j.prevetmed.2023.105945] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Revised: 05/11/2023] [Accepted: 05/16/2023] [Indexed: 05/22/2023]
Abstract
Enzyme-linked immunosorbent assay (ELISA) for viral antigen is commonly used for the diagnosis of progressive feline leukemia virus (FeLV) infection but is not able to determine the true prevalence of infection when used as the sole test. Additional testing to detect proviral DNA will identify regressive (antigen negative) FeLV infections as well as progressive infections. Therefore, this study aimed to determine the prevalence of progressive and regressive FeLV infection, outcome-associated factors, and hematologic changes. A cross-sectional study was performed on 384 cats selected from routine hospital care. Blood samples were subjected to complete blood count, ELISA for FeLV antigen and FIV antibody, and nested PCR amplifying the U3- LTR region and gag gene, which are conserved in most exogenous FeLV. The prevalence of FeLV infection was 45.6% (CI95% 40.6-50.6%). The prevalence of progressive infection (FeLV+P) was 34.4% (CI95% 29.6-39.1%), that of regressive infection (FeLV+R) was 10.4% (CI95% 7.4-13.4%), for discordant but positive results 0.8% (CI95% 0.75-0.84%), for FeLV+P coinfected with FIV 2.6% (CI95% 1.2-4.0%), and FeLV+R coinfected with FIV 1.5% (CI95% 0.3-2.7%). Male cats were three times more likely to be in the FeLV+P group. Cats coinfected with FIV were 4.8 times more likely to belong to the FeLV+R group. In the FeLV+P group, the main clinical changes were lymphoma (38.5%), anemia (24.4%), leukemia (17.9%), concomitant infections (15.4%), and feline chronic gingivostomatitis - FCGS (3.8%). In the FeLV+R group, the main clinical signs were anemia (45.4%), leukemia (18.2%), concomitant infections (18.2%), lymphoma (9.1%), and FCGS (9.1%). Cats in the FeLV+P and FeLV+R groups showed mainly thrombocytopenia (56.6% and 38.2%), non-regenerative anemia (32.8% and 23.5%), and lymphopenia (33.6% and 20.6%). Hemoglobin concentration, packed cell volume (PCV), platelet count, lymphocytes, and eosinophils in the FeLV+P and FeLV+R groups had lower medians than the control group (FeLV/FIV-uninfected, healthy). Erythrocyte and eosinophil counts were statistically different among the three groups, with the medians of the FeLV+P and FeLV+R groups being lower than those of the control group. In addition, the median PCV and band neutrophil counts were higher in FeLV+P than in FeLV+R. Our results show a high prevalence of FeLV, different factors associated with the course of infection, and more frequent and severe hematologic changes in progressive infections compared with regressive infections.
Collapse
Affiliation(s)
- Giovana Biezus
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Thierry Grima de Cristo
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Mariana da Silva Casa
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Mariângela Lovatel
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Mayara Vavassori
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | | | - Luiz Claudio Miletti
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Ubirajara Maciel da Costa
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Renata Assis Casagrande
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil.
| |
Collapse
|
8
|
Biezus G, Grima de Cristo T, Bassi das Neves G, da Silva Casa M, Barros Brizola P, Silvestre Sombrio M, Miletti LC, Assis Casagrande R. Phylogenetic identification of feline leukemia virus A and B in cats with progressive infection developing into lymphoma and leukemia. Virus Res 2023; 329:199093. [PMID: 36924831 DOI: 10.1016/j.virusres.2023.199093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 03/12/2023] [Accepted: 03/14/2023] [Indexed: 03/18/2023]
Abstract
To date, only a few studies have examined the impacts of feline leukemia virus (FeLV) subgroups on disease development in spontaneously infected cats. The present study identified FeLV-A and FeLV-B subgroups in cats with lymphoma and leukemia and explored the phylogenetic relationships of env sequences. Twenty-six cats with lymphoma (n=16) or leukemia (n=10) were selected. FeLV p27 antigen positivity was determined using ELISA, and proviral DNA in blood samples was detected using nested PCR. Positive animals in both tests were classified as cases of FeLV progressive infection and subjected to a second nested PCR for env amplification and subgroup determination. Six samples of FeLV-A and five samples of FeLV-B were sequenced using the Sanger method, and the results were used to build a phylogenetic tree and estimate evolutionary divergence. Among cats with lymphoma, 68.8% carried FeLV-AB and 31.2% FeLV-A. Among cats with leukemia, 70% carried FeLV-AB and 30% FeLV-A. Regarding cat characteristics, 50% were young, 30.8% young adults, and 19.2% adults; 88.5% were mixed-breed and 11.5% pure breed; and 42.3% were males and 57.7% were females. Among lymphomas, 62.5% were mediastinal, 31.3% multicentric, and 6.3% extranodal. Regarding histological classification, lymphoblastic and small non-cleaved-cell lymphomas were the most frequently detected. Among leukemia cases, 30% were acute lymphoid, 30% chronic myeloid, and 40% acute myeloid. Phylogenetic analysis showed that FeLV-A SC sequences were closely related to the Arena, Glasgow-1, and FeLV-FAIDS variants. Meanwhile, FeLV-B SC sequences were divergent from one another but similar to the endogenous FELV env gene (enFeLV). In conclusion, FeLV-AB is prevalent in cats with lymphoma and leukemia, highlighting the genetic diversity involved in the pathogenesis of these neoplasms in Brazil.
Collapse
Affiliation(s)
- Giovana Biezus
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Thierry Grima de Cristo
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Gabriela Bassi das Neves
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Mariana da Silva Casa
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Paula Barros Brizola
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Marina Silvestre Sombrio
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Luiz Claudio Miletti
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil
| | - Renata Assis Casagrande
- Department of Veterinary Medicine, Universidade do Estado de Santa Catarina (UDESC), Av. Luís de Camões 2090, Lages, Santa Catarina, Brazil.
| |
Collapse
|
9
|
de Mello LS, Ribeiro PR, de Almeida BA, Bandinelli MB, Sonne L, Driemeier D, Pavarini SP. Diseases associated with feline leukemia virus and feline immunodeficiency virus infection: A retrospective study of 1470 necropsied cats (2010-2020). Comp Immunol Microbiol Infect Dis 2023; 95:101963. [PMID: 36858000 DOI: 10.1016/j.cimid.2023.101963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 02/07/2023] [Accepted: 02/13/2023] [Indexed: 02/18/2023]
Abstract
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are retroviruses affecting cats worldwide, and the prevalence of infection varies considerably according to the geographic area. We retrospectively described FIV- and FeLV-associated diseases in a population of 1470 necropsied cats, of which 396 (26.9%) were infected with FeLV, 199 (13.5%) with FIV, and 134 (9.1%) with FeLV and FIV concomitantly. Cats infected with FeLV (OR 3.4) and co-infected with FeLV and FIV (OR 1.9) were more likely to have neoplasms. The diagnosis of lymphoma and leukemia was higher in cats infected with FeLV (OR 3.9 and 19.4, respectively) and coinfected with FeLV and FIV (OR 1.9 and 19.3, respectively). The odds of diagnosing bacterial diseases were higher in cats coinfected with FeLV and FIV (OR: 2.8), whereas the odds of viral diseases were higher in those infected with FeLV (OR: 2.8), with 2.2 times more diagnoses of feline infectious peritonitis. Neoplastic and infectious diseases in FIV-infected cats did not differ significantly from those in uninfected cats. According to our results, a high prevalence of retroviral infections was observed in southern Brazil, mainly in relation to FeLV. Infected cats were significantly younger than uninfected cats. The main causes of death associated with FeLV infection and FeLV and FIV coinfection were neoplastic and infectious diseases. In contrast, FIV infection was not associated with any specific condition.
Collapse
Affiliation(s)
- Lauren Santos de Mello
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - Paula Reis Ribeiro
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - Bruno Albuquerque de Almeida
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - Marcele Bettim Bandinelli
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - Luciana Sonne
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - David Driemeier
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| | - Saulo Petinatti Pavarini
- Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Rio Grande do Sul (UFRGS), 9090 Av. Bento Gonçalves, Porto Alegre, RS 91540-000, Brazil.
| |
Collapse
|
10
|
Westman ME, Giselbrecht J, Norris JM, Malik R, Green J, Burton-Bradley E, Cheang A, Meili T, Meli ML, Hartmann K, Hofmann-Lehmann R. Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany. Viruses 2023; 15:v15020491. [PMID: 36851705 PMCID: PMC9967048 DOI: 10.3390/v15020491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2023] [Revised: 01/30/2023] [Accepted: 01/31/2023] [Indexed: 02/12/2023] Open
Abstract
Different feline leukemia virus (FeLV) infection outcomes are possible in cats following natural exposure, such as progressive infections (persistent viremia), regressive infections (transient or no viremia followed by proviral persistence) and abortive infections (presence of only antibodies). Laboratory-based testing is currently required for categorization of infection outcomes in cats. The aim of this study was to evaluate the field performance of a novel, rapid, combination point-of-care (PoC) test kit commercially available in Europe (v-RetroFel®Ag/Ab; 2020-2021 version) to determine different FeLV infection outcomes by concurrent detection of FeLV antigen (p27) and antibodies against FeLV transmembrane envelope protein (p15E). A secondary aim was to evaluate the performance of the same test kit (v-RetroFel®FIV) to determine positive/negative feline immunodeficiency virus (FIV) infection status by the detection of antibodies to FIV capsid protein (p24) and transmembrane glycoprotein (gp40). Two cohorts of domestic cats were recruited and tested with v-RetroFel® using plasma or serum, including cats in Australia (n = 200) and cats in Germany (n = 170). Results from p27 antigen PoC testing, proviral DNA PCR, and neutralizing antibody testing or testing for antibodies against non-glycosylated surface unit envelope protein (p45) were used to assign cats to groups according to different FeLV infection outcomes. Testing with a laboratory-based FeLV p15E antibody ELISA was also performed for comparison. In the first cohort, v-RetroFel®Ag/Ab correctly identified 89% (109/122) FeLV-unexposed cats and 91% (21/23) progressive infections, but no regressive (0/23) or abortive (0/32) infections. In the second cohort, v-RetroFel®Ag/Ab correctly identified 94% (148/158) FeLV-unexposed cats and 100% (4/4) progressive infections, but no regressive (0/2) and only 17% (1/6) abortive infections. There was test agreement between v-RetroFel®Ab and the p15E laboratory ELISA in 58.9% of samples. As a secondary outcome of this study, the sensitivity and specificity of v-RetroFel®FIV testing in cohort 1 were 94.7% (18/19) and 98.3% (178/181), and in cohort 2, 30.0% (3/10) and 100.0% (160/160), respectively. Prior history of FIV vaccination did not produce any false-positive FIV results. In conclusion, v-RetroFel®Ag/Ab (2020-2021 version) was unable to accurately determine different FeLV infection outcomes in the field. Improvements of the test prior to application to field samples are required.
Collapse
Affiliation(s)
- Mark E. Westman
- Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
- Correspondence:
| | - Juliana Giselbrecht
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
| | - Jacqueline M. Norris
- Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
- The Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW 2006, Australia
| | - Richard Malik
- Centre for Veterinary Education, The University of Sydney, Sydney, NSW 2006, Australia
- School of Veterinary and Animal Science, Charles Sturt University, Wagga Wagga, NSW 2678, Australia
| | - Jennifer Green
- Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Elle Burton-Bradley
- Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Ashley Cheang
- Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Theres Meili
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zurich, Switzerland
| |
Collapse
|
11
|
Santos CRGR, Ferreira IT, Beranger R, Santi JP, Jardim MPDB, de Souza HJM. Undetectable proviral DNA and viral RNA levels after raltegravir administration in two cats with natural feline leukemia virus infection. BRAZILIAN JOURNAL OF VETERINARY MEDICINE 2022; 44:e003522. [PMID: 36324639 PMCID: PMC9622269 DOI: 10.29374/2527-2179.bjvm003522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Accepted: 09/22/2022] [Indexed: 01/24/2023] Open
Abstract
Feline leukemia virus (FeLV) infection was discovered over 50 years ago; however, the serious clinical changes associated with FeLV infection still have great importance in the diagnosis, prevention, and clinical management of symptomatic patients. Progressive infection with FeLV leads to a reduction in the patient's life expectancy and quality of life. This report describes the use of an antiretroviral integrase inhibitor, raltegravir, in two cats with natural FeLV infection. Raltegravir was administered orally at a dose of 40 mg/cat every 12 h in both cases. In case one, 13 weeks after starting raltegravir, RNA loads were undetectable, while proviral DNA loads were still detectable. In case two, proviral DNA loads were undetectable after 32 weeks of medication, while RNA loads were undetectable throughout the treatment. No adverse effects or laboratory test abnormalities were detected with the use of raltegravir in either patient. The patients are currently clinically healthy, still receiving the drug, and are under close observation. To our knowledge, this is the first report describing the use of raltegravir in naturally infected FeLV-positive cats and its effects on circulating viral load. Moreover, the patients described here were followed-up for a longer period than those in previously reported cases.
Collapse
Affiliation(s)
- Carla Regina Gomes Rodrigues Santos
- Veterinarian, MSc. Programa de Pós-Graduação em Medicina Veterinária (PPGMV), Departamento de Clínica e Cirurgia Veterinária (DMCV), Instituto de Veterinária (IV), Universidade Federal Rural do Rio de Janeiro (UFRRJ). Seropédica, Seropédica, RJ, Brazil.,Correspondence Carla Regina Gomes Rodrigues Santos Departamento de Clínica e Cirurgia Veterinária (DMCV), Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro – UFRRJ Rodovia BR 465, Km 7, Campus Universitário, Bairro Zona Rural CEP 23897-000 - Seropédica (RJ), Brasil E-mail: Tel: +55 (21) 96469-2559
| | | | | | - Julia Possebon Santi
- Veterinarian, Resident. Programa de Residência em Medicina Veterinária – Clínica Médica dos Gatos Domésticos, DMCV, IV, UFRRJ. Seropédica, Seropédica, RJ, Brazil.
| | - Mariana Palha de Brito Jardim
- Veterinarian, MSc. Programa de Pós-Graduação em Medicina Veterinária (PPGMV), Departamento de Clínica e Cirurgia Veterinária (DMCV), Instituto de Veterinária (IV), Universidade Federal Rural do Rio de Janeiro (UFRRJ). Seropédica, Seropédica, RJ, Brazil.
| | | |
Collapse
|
12
|
Giselbrecht J, Bergmann M, Hofmann-Lehmann R, Hartmann K. [Feline leukemia virus infection - a guide to diagnosis]. TIERARZTLICHE PRAXIS. AUSGABE K, KLEINTIERE/HEIMTIERE 2022; 50:198-212. [PMID: 35790167 DOI: 10.1055/a-1845-0750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Feline leukemia virus (FeLV) infection affects cats worldwide. The course of FeLV infection can change and vary over time. The complex pathogenesis, the availability of many different testing methods, and the interpretation of test results are often challenging for veterinarians. Cats with progressive infection (persistently p27 antigen-positive) shed FeLV mainly through saliva and are therefore considered a source of infection for uninfected cats. Diagnosing regressive infection is often challenging, since it usually cannot be detected by commonly used point of care-tests (p27 antigen test) and thus, it often remains undetected. Nevertheless, cats with regressive infection are FeLV carriers (provirus-positive) and when the immune system is suppressed, reactivation of the infection and FeLV-associated clinical signs can occur. Abortively infected cats are never viraemic, do not shed virus, and do not develop clinical signs. Abortive infection can solely be diagnosed via antibodies detection in blood. A new point-of-care test for the identification of antibodies against FeLV p15E antigen has recently been introduced on the European market and is currently being evaluated.
Collapse
Affiliation(s)
| | - Michèle Bergmann
- Medizinische Kleintierklinik, Ludwig-Maximilians-Universität München
| | | | - Katrin Hartmann
- Medizinische Kleintierklinik, Ludwig-Maximilians-Universität München
| |
Collapse
|
13
|
Xenotransfusion of Blood from Dog to Cat: Should Canine Blood Be Our First Choice for Feline Transfusion in Emergency Situations? Vet Sci 2022; 9:vetsci9030106. [PMID: 35324834 PMCID: PMC8954013 DOI: 10.3390/vetsci9030106] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 02/22/2022] [Accepted: 02/26/2022] [Indexed: 02/01/2023] Open
Abstract
Despite the ability to determine feline blood types, the transfusion of canine blood to cats is still practiced in some countries. Xenotransfusion is effective—even if its effects only last for a few days—and is not associated with serious adverse effects. It avoids the need for blood typing, and most importantly, it avoids the transmission of intraspecific infectious agents, notably the feline leukemia virus (FeLV). Transfusion with canine blood is easier, quicker and less costly than transfusion with feline blood; it is less disagreeable for the donor. In the light of these arguments, when feline blood collected according to current guidelines is not available, in particular when the donor is not confirmed to be negative for the FeLV provirus, the authors consider it to be judicious to use canine blood for feline transfusion in emergency situations; this practice is preferable to inaction and to the inoculation of an infectious agent. Allotransfusion remains preferable in non-emergency situations as a treatment of chronic compensated anaemiae or if an appropriate donor (negative for FeLV provirus) is available. However, 2–4 days after a xenotransfusion, if a clinical alteration and a significant decrease in haematocrit are observed, a transfusion with cat’s blood confirmed to be negative for FeLV provirus should be performed. Xenotransfusion should never be used twice.
Collapse
|
14
|
Chen D, Sun J, Zhu J, Ding X, Lan T, Wang X, Wu W, Ou Z, Zhu L, Ding P, Wang H, Luo L, Xiang R, Wang X, Qiu J, Wang S, Li H, Chai C, Liang L, An F, Zhang L, Han L, Zhu Y, Wang F, Yuan Y, Wu W, Sun C, Lu H, Wu J, Sun X, Zhang S, Sahu SK, Liu P, Xia J, Zhang L, Chen H, Fang D, Zeng Y, Wu Y, Cui Z, He Q, Jiang S, Ma X, Feng W, Xu Y, Li F, Liu Z, Chen L, Chen F, Jin X, Qiu W, Wang T, Li Y, Xing X, Yang H, Xu Y, Hua Y, Liu Y, Liu H, Xu X. Single cell atlas for 11 non-model mammals, reptiles and birds. Nat Commun 2021; 12:7083. [PMID: 34873160 PMCID: PMC8648889 DOI: 10.1038/s41467-021-27162-2] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Accepted: 09/18/2021] [Indexed: 01/08/2023] Open
Abstract
The availability of viral entry factors is a prerequisite for the cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Large-scale single-cell screening of animal cells could reveal the expression patterns of viral entry genes in different hosts. However, such exploration for SARS-CoV-2 remains limited. Here, we perform single-nucleus RNA sequencing for 11 non-model species, including pets (cat, dog, hamster, and lizard), livestock (goat and rabbit), poultry (duck and pigeon), and wildlife (pangolin, tiger, and deer), and investigated the co-expression of ACE2 and TMPRSS2. Furthermore, cross-species analysis of the lung cell atlas of the studied mammals, reptiles, and birds reveals core developmental programs, critical connectomes, and conserved regulatory circuits among these evolutionarily distant species. Overall, our work provides a compendium of gene expression profiles for non-model animals, which could be employed to identify potential SARS-CoV-2 target cells and putative zoonotic reservoirs.
Collapse
Affiliation(s)
| | - Jian Sun
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, 510642, China
- Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China
| | - Jiacheng Zhu
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Xiangning Ding
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Tianming Lan
- BGI-Shenzhen, Shenzhen, 518083, China
- Department of Biology, University of Copenhagen, DK-2100, Copenhagen, Denmark
| | - Xiran Wang
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, 510642, China
- Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China
| | | | - Zhihua Ou
- BGI-Shenzhen, Shenzhen, 518083, China
| | | | - Peiwen Ding
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Haoyu Wang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Lihua Luo
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Rong Xiang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Xiaoling Wang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Jiaying Qiu
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Shiyou Wang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Haimeng Li
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Chaochao Chai
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Langchao Liang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Fuyu An
- Guangdong Provincial Key Laboratory of Silviculture, Protection and Utilization, Guangdong Academy of Forestry, Guangzhou, 510520, China
| | - Le Zhang
- College of Wildlife Resources Northeast Forestry University, Harbin, 150040, China
| | - Lei Han
- College of Wildlife Resources Northeast Forestry University, Harbin, 150040, China
| | - Yixin Zhu
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | | | | | - Wendi Wu
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Chengcheng Sun
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Haorong Lu
- China National Genebank, BGI-Shenzhen, Shenzhen, 518120, China
- Shenzhen Key Laboratory of Environmental Microbial Genomics and Application, BGI-Shenzhen, Shenzhen, 518120, China
| | - Jihong Wu
- Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China
- Key Laboratory of Myopia, Ministry of Health, Shanghai, China
| | - Xinghuai Sun
- Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China
- Key Laboratory of Myopia, Ministry of Health, Shanghai, China
| | - Shenghai Zhang
- Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China
- Key Laboratory of Myopia, Ministry of Health, Shanghai, China
| | | | - Ping Liu
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Jun Xia
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Lijing Zhang
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Haixia Chen
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | | | - Yuying Zeng
- BGI-Shenzhen, Shenzhen, 518083, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Yiquan Wu
- HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892-1868, USA
| | - Zehua Cui
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, 510642, China
- Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China
| | - Qian He
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, 510642, China
- Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China
| | | | - Xiaoyan Ma
- Department of Biochemistry, University of Cambridge, Cambridge, CB21QW, UK
| | | | - Yan Xu
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Fang Li
- Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, 150 Jimo Road, Shanghai, 200120, China
| | - Zhongmin Liu
- Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, 150 Jimo Road, Shanghai, 200120, China
| | - Lei Chen
- College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, China
| | - Fang Chen
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Xin Jin
- BGI-Shenzhen, Shenzhen, 518083, China
| | - Wei Qiu
- Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China
| | - Tianjiao Wang
- Institute of Special Animal and Plant Sciences (ISAPS) of Chinese Academy of Agricultural Sciences, Changchun, China
| | - Yang Li
- Institute of Special Animal and Plant Sciences (ISAPS) of Chinese Academy of Agricultural Sciences, Changchun, China
| | - Xiumei Xing
- Institute of Special Animal and Plant Sciences (ISAPS) of Chinese Academy of Agricultural Sciences, Changchun, China
| | - Huanming Yang
- BGI-Shenzhen, Shenzhen, 518083, China
- Guangdong Provincial Academician Workstation of BGI Synthetic Genomics, BGI-Shenzhen, Shenzhen, 518120, China
| | - Yanchun Xu
- College of Wildlife Resources Northeast Forestry University, Harbin, 150040, China
- College of Wildlife and Protected Areas, Northeast Forestry University, No. 26, Hexing Road, Xiangfang District, Harbin, 150040, China
| | - Yan Hua
- Guangdong Provincial Key Laboratory of Silviculture, Protection and Utilization, Guangdong Academy of Forestry, Guangzhou, 510520, China.
| | - Yahong Liu
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, 510642, China.
- Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China.
| | - Huan Liu
- BGI-Shenzhen, Shenzhen, 518083, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
- State Key Laboratory of Agricultural Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
| | - Xun Xu
- BGI-Shenzhen, Shenzhen, 518083, China.
- Guangdong Provincial Key Laboratory of Genome Read and Write, BGI-Shenzhen, 518083, Shenzhen, China.
| |
Collapse
|
15
|
Cano-Ortiz L, Gu Q, de Sousa-Pereira P, Zhang Z, Chiapella C, Penda Twizerimana A, Lin C, Cláudia Franco A, VandeWoude S, Luedde T, Baldauf HM, Münk C. Feline Leukemia Virus-B Envelope together with its GlycoGag and Human Immunodeficiency Virus-1 Nef Mediate Resistance to Feline SERINC5. J Mol Biol 2021; 434:167421. [DOI: 10.1016/j.jmb.2021.167421] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 12/17/2021] [Accepted: 12/18/2021] [Indexed: 11/29/2022]
|
16
|
Adeno-Associated Vector-Delivered CRISPR/ SaCas9 System Reduces Feline Leukemia Virus Production In Vitro. Viruses 2021; 13:v13081636. [PMID: 34452500 PMCID: PMC8402633 DOI: 10.3390/v13081636] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 08/12/2021] [Accepted: 08/14/2021] [Indexed: 12/16/2022] Open
Abstract
Feline leukemia virus (FeLV) is a retrovirus of cats worldwide. High viral loads are associated with progressive infection and the death of the host, due to FeLV-associated disease. In contrast, low viral loads, an effective immune response, and a better clinical outcome can be observed in cats with regressive infection. We hypothesize that by lowering viral loads in progressively infected cats, using CRISPR/SaCas9-assisted gene therapy, the cat’s immune system may be permitted to direct the infection towards a regressive outcome. In a step towards this goal, the present study evaluates different adeno-associated vectors (AAVs) for their competence in delivering a gene editing system into feline cells, followed by investigations of the CRISPR/SaCas9 targeting efficiency for different sites within the FeLV provirus. Nine natural AAV serotypes, two AAV hybrid strains, and Anc80L65, an in silico predicted AAV ancestor, were tested for their potential to infect different feline cell lines and feline primary cells. AAV-DJ revealed superior infection efficiency and was thus employed in subsequent transduction experiments. The introduction of double-strand breaks, using the CRISPR/SaCas9 system targeting 12 selected FeLV provirus sites, was confirmed by T7 endonuclease 1 (T7E1), as well as Tracking of Indels by Decomposition (TIDE) analysis. The highest percentage (up to 80%) of nonhomologous end-joining (NHEJ) was found in the highly conserved gag and pol regions. Subsequent transduction experiments, using AAV-DJ, confirmed indel formation and showed a significant reduction in FeLV p27 antigen for some targets. The targeting of the FeLV provirus was efficient when using the CRISPR/SaCas9 approach in vitro. Whether the observed extent of provirus targeting will be sufficient to provide progressively FeLV-infected cats with the means to overcome the infection needs to be further investigated in vivo.
Collapse
|
17
|
Beall MJ, Buch J, Clark G, Estrada M, Rakitin A, Hamman NT, Frenden MK, Jefferson EP, Amirian ES, Levy JK. Feline Leukemia Virus p27 Antigen Concentration and Proviral DNA Load Are Associated with Survival in Naturally Infected Cats. Viruses 2021; 13:302. [PMID: 33671961 PMCID: PMC7919025 DOI: 10.3390/v13020302] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2021] [Revised: 02/09/2021] [Accepted: 02/11/2021] [Indexed: 12/18/2022] Open
Abstract
Longitudinal studies of cats naturally infected with feline leukemia virus (FeLV) are important for understanding disease outcomes. Levels of p27 antigen and copy numbers of proviral DNA have been associated with FeLV-infection courses. The purpose of this prospective study was to establish cutoff values for p27 antigen concentration and proviral DNA load that distinguished high positive from low positive groups of cats and to evaluate an association with survival. At enrollment, 254 cats were tested by point-of-care and microtiter plate enzyme-linked immunosorbent assays (ELISAs) for p27 antigen and real-time polymerase chain reaction (PCR) for proviral DNA. The 127 positive cats were retested monthly for six months and monitored for survival over the four-year study. A receiver operating characteristic-based analysis of samples with concordant or discordant qualitative results for p27 antigen and proviral DNA was used to establish cutoff values, and when applied to test results at enrollment for classifying cats as high positive or low positive, a significant difference in survival was observed. High positive cats had a median survival of 1.37 years (95% CI 0.83-2.02) from time of enrollment, while most low positive cats were still alive (93.1% survival). Quantitative results for p27 antigen concentration and proviral DNA load were highly correlated with survival times in FeLV-infected cats.
Collapse
Affiliation(s)
- Melissa J. Beall
- IDEXX Laboratories, Inc., Westbrook, ME 04092, USA; (J.B.); (G.C.); (M.E.); (A.R.)
| | - Jesse Buch
- IDEXX Laboratories, Inc., Westbrook, ME 04092, USA; (J.B.); (G.C.); (M.E.); (A.R.)
| | - Genevieve Clark
- IDEXX Laboratories, Inc., Westbrook, ME 04092, USA; (J.B.); (G.C.); (M.E.); (A.R.)
| | - Marko Estrada
- IDEXX Laboratories, Inc., Westbrook, ME 04092, USA; (J.B.); (G.C.); (M.E.); (A.R.)
| | - Andrei Rakitin
- IDEXX Laboratories, Inc., Westbrook, ME 04092, USA; (J.B.); (G.C.); (M.E.); (A.R.)
| | - Natascha T. Hamman
- Austin Pets Alive!, Austin, TX 78703, USA; (N.T.H.); (M.K.F.); (E.P.J.); (E.S.A.)
| | - Monica K. Frenden
- Austin Pets Alive!, Austin, TX 78703, USA; (N.T.H.); (M.K.F.); (E.P.J.); (E.S.A.)
| | - Ellen P. Jefferson
- Austin Pets Alive!, Austin, TX 78703, USA; (N.T.H.); (M.K.F.); (E.P.J.); (E.S.A.)
| | - E. Susan Amirian
- Austin Pets Alive!, Austin, TX 78703, USA; (N.T.H.); (M.K.F.); (E.P.J.); (E.S.A.)
| | - Julie K. Levy
- Maddie’s Shelter Medicine Program, University of Florida, Gainesville, FL 32608, USA;
| |
Collapse
|
18
|
Hofmann-Lehmann R, Hartmann K. Feline leukaemia virus infection: A practical approach to diagnosis. J Feline Med Surg 2021; 22:831-846. [PMID: 32845225 DOI: 10.1177/1098612x20941785] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PRACTICAL RELEVANCE Feline leukaemia virus (FeLV) is a retrovirus of domestic cats worldwide. Cats lacking strong FeLV-specific immunity and undergoing progressive infection commonly develop fatal FeLV-associated disease. Many aspects of FeLV infection pathogenesis have been elucidated, some during more recent years using molecular techniques. It is recommended that the FeLV status of every cat is known, since FeLV infection can influence the prognosis and clinical management of every sick cat. Moreover, knowledge of a cat's FeLV status is of epidemiological importance to prevent further spread of the infection. CLINICAL CHALLENGES Diagnosing FeLV infection remains challenging due to different outcomes of infection, which can vary over time depending on the balance between the virus and the host's immune system. Furthermore, testing for FeLV infection has become more refined over the years and now includes diagnostic assays for different viral and immunological parameters. Knowledge of FeLV infection pathogenesis, as well as the particulars of FeLV detection methods, is an important prerequisite for correct interpretation of any test results and accurate determination of a cat's FeLV status. AIMS The current review presents recent knowledge on FeLV pathogenesis, key features to be determined in FeLV infection, and frequently used FeLV detection methods, and their characteristics and interpretation. An algorithm for the diagnosis of FeLV infection in a single cat, developed by the European Advisory Board on Cat Diseases, is included, and FeLV testing in specific situations is addressed. As well as increasing awareness of this deadly infection in domestic cats, the aim is to contribute diagnostic expertise to allow veterinarians in practice to improve their recognition, and further reduce the prevalence, of FeLV infection.
Collapse
Affiliation(s)
- Regina Hofmann-Lehmann
- Prof, Dr med vet, FVH Professor of Laboratory Medicine, Director of Department of Clinical Diagnostics and Services, Head of Clinical Laboratory and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, Switzerland
| | - Katrin Hartmann
- Prof, Dr med vet, Dr habil, Dip ECVIM-CA (Internal Medicine) Professor of Internal Medicine, Head of Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Germany
| |
Collapse
|
19
|
Mesa-Sanchez I, Ferreira RRF, Cardoso I, Morais M, Flamínio M, Vieira S, de Gopegui RR, de Matos AJF. Transfusion transmissible pathogens are prevalent in healthy cats eligible to become blood donors. J Small Anim Pract 2020; 62:107-113. [PMID: 33305378 DOI: 10.1111/jsap.13257] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Revised: 10/02/2020] [Accepted: 10/14/2020] [Indexed: 11/28/2022]
Abstract
OBJECTIVES This study aims to determine the prevalence of subclinical infectious agents considered core pathogens for worldwide screening in healthy, client-owned, indoor cats eligible to become blood donors in Spain and Portugal. MATERIALS AND METHODS Blood samples of healthy, indoor, domestic cats selected to be potential blood donors were tested for feline leukaemia virus antigens, feline immunodeficiency virus antibodies and polymerase chain reactions for Mycoplasma haemofelis, Candidatus Mycoplasma haemominutum, Candidatus Mycoplasma turicensis, feline leukaemia virus provirus, Leishmania spp. and Bartonella spp. Not all donors were tested for all agents. RESULTS Overall, 5105 healthy indoor cats were tested and 8.1% (414/5105) had at least one subclinical infectious agent that is transmissible through blood product transfusion. 1.5% (77/5105) were positive for feline leukaemia virus antigens and 2.9% (148/5105) were positive for feline immunodeficiency virus antibodies, therefore they were excluded as donors. The overall prevalence of haemoplasmas in feline leukaemia virus and feline immunodeficiency virus SNAP-negative feline blood donors was 3.7% (181/4880) [1.3% (63/4880) were positive for Mycoplasma haemofelis; 2.3% (112/4880) to Candidatus Mycoplasma haemominutum and 0.12% (6/4880) to Candidatus Mycoplasma turicensis]. The prevalence of feline leukaemia provirus was 5.2% (9/173) and of Bartonella spp. was 0.2% (2/1122). None of the 173 cats were positive for Leishmania spp. CLINICAL SIGNIFICANCE The prevalence of many transfusion transmissible pathogens was relatively high in this healthy, client-owned, indoor cats eligible to become blood donors. Performing an extended screening panel that includes at least polymerase chain reactions for Mycoplasma haemofelis, Candidatus Mycoplasma haemominutum, Candidatus Mycoplasma turicensis, feline leukaemia virus provirus, and Bartonella spp., in addition to feline leukaemia virus antigens and feline immunodeficiency virus antibodies, is recommended in pet blood banks from analogous regions.
Collapse
Affiliation(s)
- I Mesa-Sanchez
- Animal Blood Bank, Passatge Rovira I Virgili No 9, Sabadell, 08205, Barcelona, Spain
| | - R R F Ferreira
- CECA-ICETA, University of Porto, 4050-083, Porto, Portugal.,Animal Blood Bank, Rua de João de Deus, n°741 4100-462, Porto, Portugal
| | - I Cardoso
- Animal Blood Bank, Rua de João de Deus, n°741 4100-462, Porto, Portugal
| | - M Morais
- Animal Blood Bank, Rua de João de Deus, n°741 4100-462, Porto, Portugal
| | - M Flamínio
- Animal Blood Bank, Rua de João de Deus, n°741 4100-462, Porto, Portugal
| | - S Vieira
- Animal Blood Bank, Rua de João de Deus, n°741 4100-462, Porto, Portugal
| | - R R de Gopegui
- Department of Animal Medicine and Surgery, Veterinary Faculty, Autonomous University of Barcelona, 08193, Barcelona, Spain
| | - A J F de Matos
- CECA-ICETA, University of Porto, 4050-083, Porto, Portugal.,Department of Veterinary Clinics, Institute for Biomedical Sciences of Abel Salazar, University of Porto, 4050-343, Porto, Portugal
| |
Collapse
|
20
|
Hartmann K, Hofmann-Lehmann R. What's New in Feline Leukemia Virus Infection. Vet Clin North Am Small Anim Pract 2020; 50:1013-1036. [PMID: 32680664 DOI: 10.1016/j.cvsm.2020.05.006] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Feline leukemia virus (FeLV) is a retrovirus with global impact on the health of domestic cats that causes tumors (mainly lymphoma), bone marrow disorders, and immunosuppression. The importance of FeLV is underestimated due to complacency associated with previous decline in prevalence. However, with this comes lowered vigilance, which, along with potential for regressively infected cats to reactivate viremia and shed the virus or develop clinical signs, can pose a risk to feline health. This article summarizes knowledge on FeLV pathogenesis, courses of infection, and factors affecting prevalance, infection outcome, and development of FeLV-associated diseases, with special focus on regressive FeLV infection.
Collapse
Affiliation(s)
- Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine LMU Munich, Veterinaerstrasse 13, Munich 80539, Germany.
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department for Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, Zurich 8057, Switzerland
| |
Collapse
|
21
|
Duda NCB, Ortiz LC, Valle SF, da Costa FVA, Varela APM, Nunes NJS, Okano FY, Franco AC, Roehe PM, González FHD. Laboratory and clinical findings and their association with viral and proviral loads in cats naturally infected with feline leukemia virus. Comp Immunol Microbiol Infect Dis 2020; 71:101491. [PMID: 32450457 DOI: 10.1016/j.cimid.2020.101491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2019] [Revised: 04/10/2020] [Accepted: 04/20/2020] [Indexed: 11/29/2022]
Abstract
This study was conducted to correlate clinical, laboratory, and bone marrow (BM) changes in cats naturally infected with feline leukemia virus and their association with viral loads in blood and BM and proviral loads in BM. Cats were classified into five groups based on antigenemia, clinical and/or laboratory findings and viral/proviral loads, according to a prospective study: symptomatic progressive (GI); asymptomatic progressive (GII); regressive (GIII); unclassified (GIV); or healthy (GV). |Correlations between these five groups and viral/proviral loads were evaluated. High viral and proviral loads were detected in GI and GII and viral loads were significantly associated with laboratory signs. Proviral loads detected in BM were significantly lower in GIII and GIV. GI cats were more likely to develop hematopoietic disorders than those from the other groups. Hematological and clinical disorders and disease severity are related to higher viral blood and proviral BM loads.
Collapse
Affiliation(s)
- Naila C B Duda
- Department of Veterinary Clinical Pathology, School of Veterinary Medicine at the Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Lucía Cano Ortiz
- Department of Microbiology, Immunology, and Parasitology, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Stella Faria Valle
- Department of Veterinary Clinical Pathology, School of Veterinary Medicine at the Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
| | - Fernanda V A da Costa
- Department of Animal Medicine, School of Veterinary Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Ana Paula Muterle Varela
- Department of Microbiology, Immunology, and Parasitology, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | | | - Felipe Yuji Okano
- Department of Veterinary Clinical Pathology, School of Veterinary Medicine at the Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Ana Cláudia Franco
- Department of Microbiology, Immunology, and Parasitology, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Paulo Michel Roehe
- Department of Microbiology, Immunology, and Parasitology, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | - Félix H D González
- Department of Veterinary Clinical Pathology, School of Veterinary Medicine at the Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| |
Collapse
|
22
|
Lockhart HL, Levy JK, Amirian ES, Hamman NT, Frenden MK. Outcome of cats referred to a specialized adoption program for feline leukemia virus-positive cats. J Feline Med Surg 2020; 22:1160-1167. [PMID: 32338565 PMCID: PMC7691564 DOI: 10.1177/1098612x20913359] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Objectives The purpose of this retrospective study was to assess outcomes of cats referred to a specialized adoption program for feline leukemia virus (FeLV)-positive cats. Methods Cats referred to an FeLV-specific adoption program between January 2018 and July 2019 at an animal shelter in Austin, TX, USA, were first identified based on their putative FeLV status as reported by the referring shelter, rescue group, veterinarian or individual. Each cat was re-screened for FeLV upon admission and subsequently deemed infected or uninfected. Data on cat source, admission date, outcome date, outcome type, signalment and comorbidities at the time of admission were extracted from the shelter database. Outcomes were recorded up to 15 December 2019. Results In total, 801 cats suspected to be infected with FeLV were referred to the FeLV adoption program. Of these, 149 (18.6%) were ultimately deemed uninfected, and infection was confirmed in 652 (81.4%) cats. Adoption was the most common outcome for FeLV-infected cats (n = 514 cats; 78.8%), followed by euthanasia or death in care (n = 109; 16.7%). Upper respiratory infection (URI) was the most common comorbidity in FeLV-infected cats (n = 106; 16.3%) at the time of admission, which was not significantly different than URI in the cats that were deemed not to be infected with FeLV (n = 29; 19.5%). Conclusions and relevance This study demonstrated high national demand for a lifesaving option for cats diagnosed with FeLV. FeLV infections could not be confirmed in approximately one in five cats referred to the FeLV adoption program, a reminder of the risk behind basing the fate of a cat on a single positive test result. The majority of cats referred to the FeLV program were adopted, demonstrating that programs centered on adopter education and post-adoption support can create lifesaving outcomes for most FeLV-infected cats, despite uncertainty regarding their long-term prognosis.
Collapse
Affiliation(s)
- Heather L Lockhart
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
| | - Julie K Levy
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
| | - E Susan Amirian
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.,Austin Pets Alive!, Austin, TX, USA
| | | | | |
Collapse
|
23
|
Molecular Detection of Feline Leukemia Virus in Oral, Conjunctival, and Rectal Mucosae Provides Results Comparable to Detection in Blood. J Clin Microbiol 2020; 58:JCM.01233-19. [PMID: 31748326 DOI: 10.1128/jcm.01233-19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Accepted: 11/08/2019] [Indexed: 12/28/2022] Open
Abstract
Feline leukemia virus (FeLV) infection causes immunosuppression, degeneration of the hematopoietic system, and fatal neoplasms. FeLV transmission occurs mainly by close social contact of infected and susceptible cats. Developing procedures for the diagnosis of feline retroviruses is crucial to reduce negative impacts on cat health and increase the number of animals tested. Blood collection requires physical or chemical restraint and is usually a stressful procedure for cats. Our objective was to evaluate the use of samples obtained from oral, conjunctival, and rectal mucosae for the molecular diagnosis of FeLV. Whole blood and oral, conjunctival, and rectal swabs were collected from a total of 145 cats. All samples were subjected to the amplification of a fragment of the gag gene of proviral DNA. Compared to blood samples used in this study as a reference, the accuracies for each PCR were 91.72, 91.23, and 85.50% for samples obtained by oral, conjunctival, and rectal swabs, respectively. The diagnostic sensitivity and specificity were 86.11 and 97.26% for the oral swabs, 90 and 92.59% for the conjunctival swabs, and 74.24 and 95.77% for the rectal swabs, respectively. The kappa values for oral, conjunctival, and rectal swabs were 0.834, 0.824, and 0.705, respectively. The diagnosis of these samples showed the presence of proviral DNA of FeLV in oral and conjunctival mucosae. In conclusion, mucosal samples for the molecular diagnosis of FeLV are an excellent alternative to venipuncture and can be safely used. It is faster, less laborious, less expensive, and well received by the animal.
Collapse
|
24
|
Little S, Levy J, Hartmann K, Hofmann-Lehmann R, Hosie M, Olah G, Denis KS. 2020 AAFP Feline Retrovirus Testing and Management Guidelines. J Feline Med Surg 2020; 22:5-30. [DOI: 10.1177/1098612x19895940] [Citation(s) in RCA: 53] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Clinical importance: Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections are found in cats worldwide. Both infections are associated with a variety of clinical signs and can impact quality of life and longevity. Scope: This document is an update of the 2008 American Association of Feline Practitioners’ feline retrovirus management guidelines and represents current knowledge on pathogenesis, diagnosis, prevention and treatment of retrovirus infections in cats. Testing and interpretation: Although vaccines are available for FeLV in many countries and for FIV in some countries, identification of infected cats remains an important factor for preventing new infections. The retrovirus status of every cat at risk of infection should be known. Cats should be tested as soon as possible after they are acquired, following exposure to an infected cat or a cat of unknown infection status, prior to vaccination against FeLV or FIV, and whenever clinical illness occurs. It might not be possible to determine a cat’s infection status based on testing at a single point in time; repeat testing using different methods could be required. Although FeLV and FIV infections can be associated with clinical disease, some infected cats, especially those infected with FIV, can live for many years with good quality of life. Management of infected cats: There is a paucity of data evaluating treatments for infected cats, especially antiretroviral and immunomodulatory drugs. Management of infected cats is focused on effective preventive healthcare strategies, and prompt identification and treatment of illness, as well as limiting the spread of infection.
Collapse
Affiliation(s)
- Susan Little
- Bytown Cat Hospital, Ottawa, ON, Canada
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | - Julie Levy
- Maddie’s Shelter Medicine Program, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, Munich, Germany
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | - Margaret Hosie
- MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | - Glenn Olah
- Albuquerque Cat Clinic, Albuquerque, NM, USA
- Charing Cross Cat Clinic, Brantford, ON, Canada
| | | |
Collapse
|
25
|
Abdollahi-Pirbazari M, Jamshidi S, Nassiri SM, Zamani-Ahmadmahmudi M. Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias. BMC Vet Res 2019; 15:460. [PMID: 31856815 PMCID: PMC6924046 DOI: 10.1186/s12917-019-2208-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2019] [Accepted: 12/04/2019] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Feline leukemia virus (FeLV) is a serious viral infection in cats. FeLV is found in some tissues, such as spleen, lymph nodes and epithelial tissues. However, there is controversy about the organ in which the virus can be reliably detected in infected cats. The purpose of this study was to determine the level of viral infection in hemolymphatic tissues, including blood, bone marrow and spleen by reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR). RESULTS A total of 31 cats with clinical signs of FeLV infection associated with at least a single lineage hematologic cytopenia were included in this study. Peripheral blood, bone marrow and spleen samples were obtained from each cat. Complete blood counts, biochemical tests, and a rapid test to detect FeLV p27 antigen in blood samples of cats were performed. Of 31 cats, 9 had anemia alone, 4 had thrombocytopenia alone, 2 had neutropenia alone, 9 had bicytopenia of anemia and thrombocytopenia, 3 had bicytopenia of anemia and neutropenia, and 4 had pancytopenia. FeLV RNA was then detected by RT-qPCR in the whole blood, bone marrow and spleen. Viral RNA copy numbers were detected in all cats by RT-qPCR whereas 24 out of 31 cats were positive for the serum FeLV antigen. We detected a significantly greater number of viral RNA in the spleen compared with the whole blood and bone marrow. CONCLUSION Spleen is a site where FeLV is most frequently detected in cats with hematologic cytopenias.
Collapse
Affiliation(s)
| | - Shahram Jamshidi
- Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
| | - Seyed Mahdi Nassiri
- Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Qareeb St., Azadi Ave, Tehran, Iran.
| | - Mohamad Zamani-Ahmadmahmudi
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran
| |
Collapse
|
26
|
Studer N, Lutz H, Saegerman C, Gönczi E, Meli ML, Boo G, Hartmann K, Hosie MJ, Moestl K, Tasker S, Belák S, Lloret A, Boucraut-Baralon C, Egberink HF, Pennisi MG, Truyen U, Frymus T, Thiry E, Marsilio F, Addie D, Hochleithner M, Tkalec F, Vizi Z, Brunetti A, Georgiev B, Ludwig-Begall LF, Tschuor F, Mooney CT, Eliasson C, Orro J, Johansen H, Juuti K, Krampl I, Kovalenko K, Šengaut J, Sobral C, Borska P, Kovaříková S, Hofmann-Lehmann R. Pan-European Study on the Prevalence of the Feline Leukaemia Virus Infection - Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses 2019; 11:v11110993. [PMID: 31671816 PMCID: PMC6893802 DOI: 10.3390/v11110993] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 10/26/2019] [Accepted: 10/27/2019] [Indexed: 01/09/2023] Open
Abstract
Feline leukaemia virus (FeLV) is a retrovirus associated with fatal disease in progressively infected cats. While testing/removal and vaccination led to a decreased prevalence of FeLV, recently, this decrease has reportedly stagnated in some countries. This study aimed to prospectively determine the prevalence of FeLV viraemia in cats taken to veterinary facilities in 32 European countries. FeLV viral RNA was semiquantitatively detected in saliva, using RT-qPCR as a measure of viraemia. Risk and protective factors were assessed using an online questionnaire to report geographic, demographic, husbandry, FeLV vaccination, and clinical data. The overall prevalence of FeLV viraemia in cats visiting a veterinary facility, of which 10.4% were shelter and rescue cats, was 2.3% (141/6005; 95% CI: 2.0%–2.8%) with the highest prevalences in Portugal, Hungary, and Italy/Malta (5.7%–8.8%). Using multivariate analysis, seven risk factors (Southern Europe, male intact, 1–6 years of age, indoor and outdoor or outdoor-only living, living in a group of ≥5 cats, illness), and three protective factors (Northern Europe, Western Europe, pedigree cats) were identified. Using classification and regression tree (CART) analysis, the origin of cats in Europe, pedigree, and access to outdoors were important predictors of FeLV status. FeLV-infected sick cats shed more viral RNA than FeLV-infected healthy cats, and they suffered more frequently from anaemia, anorexia, and gingivitis/stomatitis than uninfected sick cats. Most cats had never been FeLV-vaccinated; vaccination rates were indirectly associated with the gross domestic product (GDP) per capita. In conclusion, we identified countries where FeLV was undetectable, demonstrating that the infection can be eradicated and highlighting those regions where awareness and prevention should be increased.
Collapse
Affiliation(s)
- Nadine Studer
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
| | - Hans Lutz
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
| | - Claude Saegerman
- Department of Infectious and Parasitic Diseases, Research Unit of Epidemiology and Risk Analysis Applied to Veterinary, Fundamental and Applied Research for Animal and Health (FARAH) Center, Faculty of Veterinary Medicine, University of Liège, B-4000 Liège, Belgium.
| | - Enikö Gönczi
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
| | - Marina L Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
| | - Gianluca Boo
- Department of Geography, University of Zurich, 8057 Zurich, Switzerland.
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany.
| | - Margaret J Hosie
- MRC- University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.
| | - Karin Moestl
- Institute of Virology, Department for Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
| | - Séverine Tasker
- Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK & Chief Medical Officer, Linnaeus Group, Shirley, Solihull B90 4BN, UK.
| | - Sándor Belák
- Swedish University of Agricultural Sciences (SLU), Department of Biomedical Sciences and Veterinary Public Health (BVF), 750 07 Uppsala, Sweden.
| | - Albert Lloret
- Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
| | | | - Herman F Egberink
- University of Utrecht, Faculty of Veterinary Medicine, Department of Infectious Diseases and Immunology, 3584 CL Utrecht, Netherlands.
| | - Maria-Grazia Pennisi
- Dipartimento di Scienze Veterinarie, Università di Messina, 98168 Messina, Italy.
| | - Uwe Truyen
- Institute of Animal Hygiene and Veterinary Public Health, University of Leipzig, 04103 Leipzig, Germany.
| | - Tadeusz Frymus
- Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, 02-787 Warsaw, Poland.
| | - Etienne Thiry
- Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH Research Centre, Faculty of Veterinary Medicine, Liège University, B-4000 Liège, Belgium.
| | - Fulvio Marsilio
- Faculty of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy.
| | - Diane Addie
- Veterinary Diagnostic Services, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
| | | | - Filip Tkalec
- Veterinarska klinika Kreszinger, 10360 Sesvete, Zagreb, Croatia.
| | - Zsuzsanna Vizi
- University of Veterinary Medicine, 1078 Budapest, Hungary.
| | - Anna Brunetti
- School of Veterinary Medicine, University of Glasgow, Glasgow G61 1QH, UK.
| | - Boyko Georgiev
- Institute of Biology and Immunology of Reproduction, 1113 Sofia, Bulgaria.
| | - Louisa F Ludwig-Begall
- Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH Research Centre, Faculty of Veterinary Medicine, Liège University, B-4000 Liège, Belgium.
| | - Flurin Tschuor
- Kleintierklinik BolligerTschuor AG, Fachtierärzte für Kleintiere, 4665 Oftringen - Zofingen, Switzerland.
| | - Carmel T Mooney
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
| | - Catarina Eliasson
- Jamaren - Swedish Veterinary Feline Study Group, 275 71 Lövestad, Sweden.
| | | | | | - Kirsi Juuti
- CatVet Kissaklinikka, 00400 Helsinki, Finland.
| | - Igor Krampl
- Slovak Small Animal Veterinary Association, 821 02 Bratislava, Slovakia.
| | - Kaspars Kovalenko
- Faculty of Veterinary Medicine, Latvia University of Lifesciences and Technologies, LV-3004 Jelgava, Latvia.
| | - Jakov Šengaut
- Jakov Veterinary Centre, Gerosios Vilties g. 1, LT-03147 Vilnius, Lithuania.
| | | | - Petra Borska
- Small Animal Emergency Clinic, 637 00 Brno-Jundrov, Czech Republic.
| | - Simona Kovaříková
- Department of Animal Protection, Welfare and Behavior, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
| |
Collapse
|
27
|
Evaluation of a quantitative enzyme-linked immunosorbent assay for feline leukemia virus p27 antigen and comparison to proviral DNA loads by real-time polymerase chain reaction. Comp Immunol Microbiol Infect Dis 2019; 67:101348. [PMID: 31527012 DOI: 10.1016/j.cimid.2019.101348] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 08/14/2019] [Accepted: 08/30/2019] [Indexed: 11/23/2022]
Abstract
Feline leukemia virus (FeLV) is an oncogenic retrovirus of cats. While higher viral RNA and proviral DNA loads have been correlated with progressive infections and disease, a similar correlation has been suggested for p27 antigen concentrations. This analytical study compared the results of a quantitative ELISA for p27 antigen with quantitative real-time PCR results for FeLV proviral DNA in patient samples. A significant positive correlation between copies of proviral DNA and the concentration of p27 antigen was identified (r = 0.761, P < 0.0001). Samples with high proviral DNA loads, at least 1 × 106 copies/mL of whole blood, typically had p27 antigen concentrations greater than 30 ng/mL in plasma. Samples with proviral DNA loads below this level all had concentrations of p27 antigen in plasma that were less than 10 ng/mL. Given this correlation, it is hypothesized that the concentration of p27 antigen at a given point in time may help to indicate the likelihood of a progressive or regressive infection similar to what has been demonstrated for proviral DNA loads.
Collapse
|
28
|
Prevalence, Geographic Distribution, Risk Factors and Co-Infections of Feline Gammaherpesvirus Infections in Domestic Cats in Switzerland. Viruses 2019; 11:v11080721. [PMID: 31390829 PMCID: PMC6723517 DOI: 10.3390/v11080721] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Revised: 07/31/2019] [Accepted: 08/04/2019] [Indexed: 12/14/2022] Open
Abstract
Recently, a gammaherpesvirus was described in domestic cats (FcaGHV1). The goal of the present study was to investigate the presence of FcaGHV1 in Swiss domestic cats and analyze potential risk factors. Blood samples from 881 cats presented to veterinarians in all Swiss cantons and from 91 stray cats and neoplastic tissue samples from 17 cats with lymphoma were evaluated. FcaGHV1 was detected by real-time PCR targeting the glycoprotein B gene, followed by sequencing. Blood samples were also tested for feline hemoplasmas, feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). The molecular prevalence of FcaGHV1 was 6.0% (95% confidence interval (CI), 4.5–7.8%) in cats presented to veterinarians and 5.5% (95% CI, 1.8–12.4%) in stray cats. FcaGHV1 PCR-positive cats originated from 19/26 Swiss cantons. Factors significantly associated with FcaGHV1 detection included male sex, age >3 years, nonpedigree status and co-infection with FIV and hemoplasmas. Moreover, FeLV viremia tended to be associated with FcaGHV1 detection. High FcaGHV1 blood loads were found more frequently in FeLV-viremic cats and less frequently in hemoplasma-infected cats than in uninfected cats. Clinical information was unavailable for most of the 881 cats, but leukemia, carcinoma and cardiomyopathy were reported in FcaGHV1-positive cats. None of the tissue samples from the 17 cats with lymphoma tested positive for FcaGHV1. Sequence analyses revealed homogeneity among the Swiss isolates and >99.7% identity to published FcaGHV1 sequences. In conclusion, FcaGHV1 is present in Switzerland with a similar prevalence in cats presented to veterinarians and in stray cats. The pathogenic potential of FcaGHV1 needs further evaluation.
Collapse
|
29
|
Westman M, Norris J, Malik R, Hofmann-Lehmann R, Harvey A, McLuckie A, Perkins M, Schofield D, Marcus A, McDonald M, Ward M, Hall E, Sheehy P, Hosie M. The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia. Viruses 2019; 11:v11060503. [PMID: 31159230 PMCID: PMC6630418 DOI: 10.3390/v11060503] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Revised: 05/21/2019] [Accepted: 05/29/2019] [Indexed: 12/11/2022] Open
Abstract
A field study was undertaken to (i) measure the prevalence of feline leukaemia virus (FeLV) exposure and FeLV infection in a cross-section of healthy Australian pet cats; and (ii) investigate the outcomes following natural FeLV exposure in two Australian rescue facilities. Group 1 (n = 440) consisted of healthy client-owned cats with outdoor access, predominantly from eastern Australia. Groups 2 (n = 38) and 3 (n = 51) consisted of a mixture of healthy and sick cats, group-housed in two separate rescue facilities in Sydney, Australia, tested following identification of index cases of FeLV infection in cats sourced from these facilities. Diagnostic testing for FeLV exposure/infection included p27 antigen testing using three different point-of-care FeLV kits and a laboratory-based ELISA, real-time polymerase chain reaction (qPCR) testing to detect FeLV proviral DNA in leukocytes, real-time reverse-transcription PCR (qRT-PCR) testing to detect FeLV RNA in plasma, and neutralising antibody (NAb) testing. Cats were classified as FeLV-uninfected (FeLV-unexposed and presumptively FeLV-abortive infections) or FeLV-infected (presumptively regressive and presumptively progressive infections). In Group 1, 370 FeLV-unexposed cats (370/440, 84%), 47 abortive infections (47/440, 11%), nine regressive infections (9/440, 2%), and two progressive infections (2/440, 0.5%) were identified, and 12 FeLV-uninfected cats (12/440, 3%) were unclassifiable as FeLV-unexposed or abortive infections due to insufficient samples available for NAb testing. In Groups 2 and 3, 31 FeLV-unexposed cats (31/89, 35%), eight abortive infections (8/89, 9%), 22 regressive infections (22/89; 25%), and 19 progressive infections (19/89; 21%) were discovered, and nine FeLV-uninfected cats (9/89; 10%) were unclassifiable due to insufficient samples available for NAb testing. One of the presumptively progressively-infected cats in Group 3 was likely a focal FeLV infection. Two other presumptively progressively-infected cats in Group 3 may have been classified as regressive infections with repeated testing, highlighting the difficulties associated with FeLV diagnosis when sampling cats at a single time point, even with results from a panel of FeLV tests. These results serve as a reminder to Australian veterinarians that the threat of FeLV to the general pet cat population remains high, thus vigilant FeLV testing, separate housing for FeLV-infected cats, and FeLV vaccination of at-risk cats is important, particularly in group-housed cats in shelters and rescue facilities, where outbreaks of FeLV infection can occur.
Collapse
Affiliation(s)
- Mark Westman
- Sydney School of Veterinary Science, The University of Sydney, Camperdown, 2006 NSW, Australia.
| | - Jacqueline Norris
- Sydney School of Veterinary Science, The University of Sydney, Camperdown, 2006 NSW, Australia.
| | - Richard Malik
- Centre for Veterinary Education, The University of Sydney, Camperdown, 2006 NSW, Australia.
| | - Regina Hofmann-Lehmann
- Clinical Laboratory and Centre for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zürich, Switzerland.
| | - Andrea Harvey
- Small Animal Specialist Hospital, 1 Richardson Place, North Ryde, Sydney, 2113 NSW, Australia.
| | - Alicia McLuckie
- Sydney School of Veterinary Science, The University of Sydney, Camperdown, 2006 NSW, Australia.
| | | | | | - Alan Marcus
- Sydney School of Veterinary Science, The University of Sydney, Camperdown, 2006 NSW, Australia.
| | - Mike McDonald
- Veterinary Diagnostic Services, The University of Glasgow, Glasgow, Scotland G61 1QH, UK.
| | - Michael Ward
- Sydney School of Veterinary Science, The University of Sydney, Camden, 2570 NSW, Australia.
| | - Evelyn Hall
- Sydney School of Veterinary Science, The University of Sydney, Camden, 2570 NSW, Australia.
| | - Paul Sheehy
- Sydney School of Veterinary Science, The University of Sydney, Camden, 2570 NSW, Australia.
| | - Margaret Hosie
- MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.
| |
Collapse
|
30
|
Spada E, Perego R, Sgamma EA, Proverbio D. Survival time and effect of selected predictor variables on survival in owned pet cats seropositive for feline immunodeficiency and leukemia virus attending a referral clinic in northern Italy. Prev Vet Med 2017; 150:38-46. [PMID: 29406082 DOI: 10.1016/j.prevetmed.2017.12.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2017] [Revised: 11/27/2017] [Accepted: 12/01/2017] [Indexed: 12/18/2022]
Abstract
Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are among the most important feline infectious diseases worldwide. This retrospective study investigated survival times and effects of selected predictor factors on survival time in a population of owned pet cats in Northern Italy testing positive for the presence of FIV antibodies and FeLV antigen. One hundred and three retrovirus-seropositive cats, 53 FIV-seropositive cats, 40 FeLV-seropositive cats, and 10 FIV+FeLV-seropositive cats were included in the study. A population of 103 retrovirus-seronegative age and sex-matched cats was selected. Survival time was calculated and compared between retrovirus-seronegative, FIV, FeLV and FIV+FeLV-seropositive cats using Kaplan-Meier survival analysis. Cox proportional-hazards regression analysis was used to study the effect of selected predictor factors (male gender, peripheral blood cytopenia as reduced red blood cells - RBC- count, leukopenia, neutropenia and lymphopenia, hypercreatininemia and reduced albumin to globulin ratio) on survival time in retrovirus-seropositive populations. Median survival times for seronegative cats, FIV, FeLV and FIV+FeLV-seropositive cats were 3960, 2040, 714 and 77days, respectively. Compared to retrovirus-seronegative cats median survival time was significantly lower (P<0.000) in FeLV and FIV+FeLV-seropositive cats. Median survival time in FeLV and FIV+FeLV-seropositive cats was also significant lower (P<0.000) when compared to FIV-seropositive cats. Hazard ratio of death in FeLV and FIV+FeLV-seropositive cats being respectively 3.4 and 7.4 times higher, in comparison to seronegative cats and 2.3 and 4.8 times higher in FeLV and FIV+FeLV-seropositive cats as compared to FIV-seropositive cats. A Cox proportional-hazards regression analysis showed that FIV and FeLV-seropositive cats with reduced RBC counts at time of diagnosis of seropositivity had significantly shorter survival times when compared to FIV and FeLV-seropositive cats with normal RBC counts at diagnosis. In summary, FIV-seropositive status did not significantly affect longevity of cats in this study, unlike FeLV and FIV+FeLV-seropositivity. Reduced RBC counts at time of FIV and FeLV diagnosis could impact negatively on the longevity of seropositive cats and therefore blood counts should always be evaluated at diagnosis and follow-up of retrovirus-seropositive cats.
Collapse
Affiliation(s)
- Eva Spada
- Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy.
| | - Roberta Perego
- Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy
| | - Elena Assunta Sgamma
- Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy
| | - Daniela Proverbio
- Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy
| |
Collapse
|
31
|
Filoni C, Helfer-Hungerbuehler AK, Catão-Dias JL, Marques MC, Torres LN, Reinacher M, Hofmann-Lehmann R. Putative progressive and abortive feline leukemia virus infection outcomes in captive jaguarundis (Puma yagouaroundi). Virol J 2017; 14:226. [PMID: 29149857 PMCID: PMC5693524 DOI: 10.1186/s12985-017-0889-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2017] [Accepted: 11/02/2017] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Feline leukemia virus (FeLV) is an exogenous gammaretrovirus of domestic cats (Felis catus) and some wild felids. The outcomes of FeLV infection in domestic cats vary according to host susceptibility, virus strain, and infectious challenge dose. Jaguarundis (Puma yagouaroundi) are small wild felids from South and Central America. We previously reported on FeLV infections in jaguarundis. We hypothesized here that the outcomes of FeLV infection in P. yagouaroundi mimic those observed in domestic cats. The aim of this study was to investigate the population of jaguarundis at Fundação Parque Zoológico de São Paulo for natural FeLV infection and resulting outcomes. METHODS We investigated the jaguarundis using serological and molecular methods and monitored them for FeLV-related diseases for 5 years. We retrieved relevant biological and clinical information for the entire population of 23 jaguarundis held at zoo. Post-mortem findings from necropsies were recorded and histopathological and immunohistopathological analyses were performed. Sequencing and phylogenetic analyses were performed for FeLV-positive samples. For sample prevalence, 95% confidence intervals (CI) were calculated. Fisher's exact test was used to compare frequencies between infected and uninfected animals. P-values <0.05 were considered significant. RESULTS In total, we detected evidence of FeLV exposure in four out of 23 animals (17%; 95% CI 5-39%). No endogenous FeLV (enFeLV) sequences were detected. An intestinal B-cell lymphoma in one jaguarundi was not associated with FeLV. Two jaguarundis presented FeLV test results consistent with an abortive FeLV infection with seroconversion, and two other jaguarundis had results consistent with a progressive infection and potentially FeLV-associated clinical disorders and post-mortem changes. Phylogenetic analysis of env revealed the presence of FeLV-A, a common origin of the virus in both animals (100% identity) and the closest similarity to FeLV-FAIDS and FeLV-3281 (98.4% identity), originally isolated from cats in the USA. CONCLUSIONS We found evidence of progressive and abortive FeLV infection outcomes in jaguarundis, and domestic cats were probably the source of infection in these jaguarundis.
Collapse
Affiliation(s)
- Claudia Filoni
- Institute of Biosciences, Department of Microbiology and Immunology, São Paulo State University (UNESP), Campus Botucatu, Rua Professor Doutor Antonio Celso Wagner Zanin SN, Botucatu, São Paulo, 18618-689, Brazil.
| | - A Katrin Helfer-Hungerbuehler
- Vetsuisse Faculty, Clinical Laboratory and Center for Clinical Studies, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland
| | - José Luiz Catão-Dias
- School of Veterinary Medicine and Animal Sciences, Department of Pathology, University of São Paulo (USP), Av. Prof. Orlando Marques de Paiva 87, São Paulo, 05508-270, São Paulo, Brazil
| | - Mara Cristina Marques
- Fundação Parque Zoológico de São Paulo (FPZSP), Av. Miguel Stéfano 4241, São Paulo, São Paulo, 04301-905, Brazil
| | - Luciana Neves Torres
- School of Veterinary Medicine and Animal Sciences, Veterinary Hospital (HOVET), University of São Paulo (USP), Av. Prof. Orlando Marques de Paiva 87, São Paulo, 05508-270, São Paulo, Brazil
| | - Manfred Reinacher
- Institute of Veterinary Pathology, University of Giessen, Frankfurter Strasse 96, Giessen, 35392, Germany
| | - Regina Hofmann-Lehmann
- Vetsuisse Faculty, Clinical Laboratory and Center for Clinical Studies, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland
| |
Collapse
|
32
|
Wilkes RP, Anis E, Dunbar D, Lee PYA, Tsai YL, Lee FC, Chang HFG, Wang HTT, Graham EM. Rapid and sensitive insulated isothermal PCR for point-of-need feline leukaemia virus detection. J Feline Med Surg 2017; 20:362-369. [PMID: 28589743 PMCID: PMC5871024 DOI: 10.1177/1098612x17712847] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Objectives Feline leukaemia virus (FeLV), a gamma retrovirus, causes diseases of the
feline haematopoietic system that are invariably fatal. Rapid and accurate
testing at the point-of-need (PON) supports prevention of virus spread and
management of clinical disease. This study evaluated the performance of an
insulated isothermal PCR (iiPCR) that detects proviral DNA, and a reverse
transcription (RT)-iiPCR that detects both viral RNA and proviral DNA, for
FeLV detection at the PON. Methods Mycoplasma haemofelis, feline coronavirus, feline
herpesvirus, feline calicivirus and feline immunodeficiency virus were used
to test analytical specificity. In vitro transcribed RNA, artificial
plasmid, FeLV strain American Type Culture Collection VR-719 and a clinical
FeLV isolate were used in the analytical sensitivity assays. A retrospective
study including 116 clinical plasma and serum samples that had been tested
with virus isolation, real-time PCR and ELISA, and a prospective study
including 150 clinical plasma and serum samples were implemented to evaluate
the clinical performances of the iiPCR-based methods for FeLV detection. Results Ninety-five percent assay limit of detection was calculated to be 16 RNA and
five DNA copies for the RT-iiPCR, and six DNA copies for the iiPCR. Both
reactions had analytical sensitivity comparable to a reference real-time PCR
(qPCR) and did not detect five non-target feline pathogens. The clinical
performance of the RT-iiPCR and iiPCR had 98.82% agreement (kappa[κ] = 0.97)
and 100% agreement (κ = 1.0), respectively, with the qPCR (n = 85). The
agreement between an automatic nucleic extraction/RT-iiPCR system and virus
isolation to detect FeLV in plasma or serum was 95.69% (κ = 0.95) and 98.67%
(κ = 0.85) in a retrospective (n = 116) and a prospective (n = 150) study,
respectively. Conclusions and relevance These results suggested that both RT-iiPCR and iiPCR assays can serve as
reliable tools for PON FeLV detection.
Collapse
Affiliation(s)
- Rebecca P Wilkes
- 1 Clinical Virology Laboratory, University of Tennessee Veterinary Medical Center, Knoxville, TN, USA.,*Current address: Veterinary Diagnostic and Investigational Laboratory, College of Veterinary Medicine, University of Georgia, Tifton, GA, USA
| | - Eman Anis
- 1 Clinical Virology Laboratory, University of Tennessee Veterinary Medical Center, Knoxville, TN, USA.,2 Department of Virology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Beheira, Egypt.,*Current address: Veterinary Diagnostic and Investigational Laboratory, College of Veterinary Medicine, University of Georgia, Tifton, GA, USA
| | - Dawn Dunbar
- 3 Veterinary Diagnostic Services, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
| | | | | | | | | | | | - Elizabeth M Graham
- 3 Veterinary Diagnostic Services, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
| |
Collapse
|
33
|
Levy JK, Crawford PC, Tucker SJ. Performance of 4 Point-of-Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus. J Vet Intern Med 2017; 31:521-526. [PMID: 28158913 PMCID: PMC5354053 DOI: 10.1111/jvim.14648] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2016] [Revised: 10/29/2016] [Accepted: 11/28/2016] [Indexed: 12/19/2022] Open
Abstract
Background More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV antibody combination test kits. Animals Surplus serum and plasma from diagnostic samples submitted by animal shelters, diagnostic laboratories, veterinary clinics, and cat research colonies. None of the cats had been vaccinated against FIV. The final sample set included 146 FeLV+, 154 FeLV−, 94 FIV+, and 97 FIV− samples. Methods Prospective, blind comparison to a gold standard: Samples were evaluated in 4 different point‐of‐care tests by ELISA antigen plate tests (FeLV) and virus isolation (FIV) as the reference standards. All test results were visually read by 2 blinded observers. Results Sensitivity and specificity, respectively, for FeLV were SNAP® (100%/100%), WITNESS® (89.0%/95.5%), Anigen® (91.8%/95.5%), and VetScan® (85.6%/85.7%). Sensitivity and specificity for FIV were SNAP® (97.9%/99.0%), WITNESS® (94.7%/100%), Anigen® (96.8%/99.0%), and VetScan® (91.5%/99.0%). Conclusions and Clinical Importance The SNAP® test had the best performance for FeLV, but there were no significant differences for FIV. In typical cat populations with seroprevalence of 1–5%, a majority of positive results reported by most point‐of‐care test devices would be false‐positives. This could result in unnecessary segregation or even euthanasia.
Collapse
Affiliation(s)
- J K Levy
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL
| | - P Cynda Crawford
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL
| | - S J Tucker
- Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, Gainesville, FL
| |
Collapse
|
34
|
Westman ME, Malik R, Hall E, Sheehy PA, Norris JM. Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva. Comp Immunol Microbiol Infect Dis 2017; 50:88-96. [DOI: 10.1016/j.cimid.2016.11.014] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Revised: 11/22/2016] [Accepted: 11/22/2016] [Indexed: 10/20/2022]
|
35
|
Wardrop KJ, Birkenheuer A, Blais MC, Callan MB, Kohn B, Lappin MR, Sykes J. Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens. J Vet Intern Med 2016; 30:15-35. [PMID: 26806261 PMCID: PMC4913655 DOI: 10.1111/jvim.13823] [Citation(s) in RCA: 69] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2015] [Revised: 11/23/2015] [Accepted: 11/23/2015] [Indexed: 12/02/2022] Open
Abstract
An update on the 2005 American College of Veterinary Internal Medicine (ACVIM) Consensus Statement on blood donor infectious disease screening was presented at the 2015 ACVIM Forum in Indianapolis, Indiana, followed by panel and audience discussion. The updated consensus statement is presented below. The consensus statement aims to provide guidance on appropriate blood‐borne pathogen testing for canine and feline blood donors in North America.
Collapse
Affiliation(s)
- K J Wardrop
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA
| | - A Birkenheuer
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC
| | - M C Blais
- Department of Clinical Sciences, Faculté de médecine vétérinaire, Université de Montreal, Montreal, QC
| | - M B Callan
- Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
| | - B Kohn
- Clinic of Small Animals, Faculty of Veterinary Medicine, Freie Universitat Berlin, Berlin, Germany
| | - M R Lappin
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO
| | - J Sykes
- Department of Medicine and Epidemiology, University of California, Davis, CA
| |
Collapse
|
36
|
Liu J, O'Connor T, Beall M, Chandrashekar R, Lappin M. Evaluation of rapid diagnostic test kits for feline leukemia virus infection using samples from naturally infected cats. JFMS Open Rep 2016; 2:2055116916667757. [PMID: 28491433 PMCID: PMC5362870 DOI: 10.1177/2055116916667757] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/07/2016] [Indexed: 12/16/2022] Open
Abstract
Objectives Feline leukemia virus (FeLV) is a potentially life-threatening oncogenic retrovirus. The p27 viral core protein is produced by the virus in infected feline cells, is found in the cytoplasm in several blood cells and can be free in the serum and plasma. ELISA or particle-based immunoassay are commonly used to detect the presence of the p27 core protein in samples obtained from blood. The objective of this study was to compare the performance of several in-clinic tests: the SNAP Feline Triple Test (IDEXX Laboratories), the WITNESS FeLV-FIV Test (Zoetis) and the VetScan Feline FeLV/FIV Rapid Test (Abaxis). Methods The sample population (100 positive, 105 negative samples) consisted of serum and plasma samples submitted to IDEXX’s worldwide reference laboratory for feline retrovirus testing. Virus isolation and reverse transcriptase PCR results were not available and so samples were judged to be positive or negative based on the results of the ViraCHEK FeLV (Zoetis) microtiter plate assay. Results The percentage of samples positive and negative for FeLV p27 antigen using the three in-clinic tests compared with the ViraCHEK method were as follows: IDEXX Feline Triple (positive 98.0%, negative 100%); Zoetis WITNESS (positive 79.0%, negative 97.1%); Abaxis VetScan (positive 73.0%, negative 97.1%). Conclusions and relevance The SNAP Feline Triple Test demonstrated a high level of agreement for FeLV-positive and FeLV-negative samples when assessed in this model. Results of FeLV assays can vary among tests.
Collapse
Affiliation(s)
| | | | | | | | - Michael Lappin
- Center for Companion Animal Studies, Colorado State University, Fort Collins, CO, USA
| |
Collapse
|
37
|
Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines. CLINICAL AND VACCINE IMMUNOLOGY : CVI 2016; 22:1294-5. [PMID: 26604264 DOI: 10.1128/cvi.00497-15] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
38
|
Ramírez H, Autran M, García MM, Carmona MÁ, Rodríguez C, Martínez HA. Genotyping of feline leukemia virus in Mexican housecats. Arch Virol 2016; 161:1039-45. [PMID: 26747244 PMCID: PMC4819734 DOI: 10.1007/s00705-015-2740-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2015] [Accepted: 12/21/2015] [Indexed: 02/05/2023]
Abstract
Feline leukemia virus (FeLV) is a retrovirus with variable rates of infection globally. DNA was obtained from cats' peripheral blood mononuclear cells, and proviral DNA of pol and env genes was detected using PCR. Seventy-six percent of cats scored positive for FeLV using env-PCR; and 54 %, by pol-PCR. Phylogenetic analysis of both regions identified sequences that correspond to a group that includes endogenous retroviruses. They form an independent branch and, therefore, a new group of endogenous viruses. Cat gender, age, outdoor access, and cohabitation with other cats were found to be significant risk factors associated with the disease. This strongly suggests that these FeLV genotypes are widely distributed in the studied feline population in Mexico.
Collapse
Affiliation(s)
- Hugo Ramírez
- Facultad de Estudios Superiores Cuautitlán, Veterinary Medicine, Virology, Genetics and Molecular Biology Laboratory, Campus 4, Cuautitlán Izcalli Estado de México, Universidad Nacional Autónoma de México, Km 2.5 Carretera Cuautitlán-Teoloyucan, San Sebastián Xhala, CP. 54714, Cuautitlán Izcalli, Estado de México, México.
| | - Marcela Autran
- Facultad de Estudios Superiores Cuautitlán, Veterinary Medicine, Virology, Genetics and Molecular Biology Laboratory, Campus 4, Cuautitlán Izcalli Estado de México, Universidad Nacional Autónoma de México, Km 2.5 Carretera Cuautitlán-Teoloyucan, San Sebastián Xhala, CP. 54714, Cuautitlán Izcalli, Estado de México, México
| | - M Martha García
- Immuno-Virology Laboratory, Department of Immunological Research, UMAE Pediatrics Hospital, XXI Century National Medical Center, IMSS, Av. Cuauhtémoc 330, Col. Doctores, CP. 06725, Ciudad de México, México
| | - M Ángel Carmona
- Facultad de Estudios Superiores Cuautitlán, Veterinary Medicine, Virology, Genetics and Molecular Biology Laboratory, Campus 4, Cuautitlán Izcalli Estado de México, Universidad Nacional Autónoma de México, Km 2.5 Carretera Cuautitlán-Teoloyucan, San Sebastián Xhala, CP. 54714, Cuautitlán Izcalli, Estado de México, México
| | - Cecilia Rodríguez
- Facultad de Estudios Superiores Cuautitlán, Veterinary Medicine, Virology, Genetics and Molecular Biology Laboratory, Campus 4, Cuautitlán Izcalli Estado de México, Universidad Nacional Autónoma de México, Km 2.5 Carretera Cuautitlán-Teoloyucan, San Sebastián Xhala, CP. 54714, Cuautitlán Izcalli, Estado de México, México
| | - H Alejandro Martínez
- Facultad de Estudios Superiores Cuautitlán, Veterinary Medicine, Virology, Genetics and Molecular Biology Laboratory, Campus 4, Cuautitlán Izcalli Estado de México, Universidad Nacional Autónoma de México, Km 2.5 Carretera Cuautitlán-Teoloyucan, San Sebastián Xhala, CP. 54714, Cuautitlán Izcalli, Estado de México, México
| |
Collapse
|
39
|
Nesina S, Katrin Helfer-Hungerbuehler A, Riond B, Boretti FS, Willi B, Meli ML, Grest P, Hofmann-Lehmann R. Retroviral DNA--the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats. Retrovirology 2015; 12:105. [PMID: 26689419 PMCID: PMC4687292 DOI: 10.1186/s12977-015-0231-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2015] [Accepted: 12/09/2015] [Indexed: 11/23/2022] Open
Abstract
Background
The feline leukemia virus (FeLV) is a gamma-retrovirus of domestic cats that was discovered half a century ago. Cats that are infected with FeLV may develop a progressive infection resulting in persistent viremia, immunodeficiency, tumors, anemia and death. A significant number of cats mount a protective immune response that suppresses viremia; these cats develop a regressive infection characterized by the absence of viral replication and the presence of low levels of proviral DNA. The biological importance of these latter provirus carriers is largely unknown. Results Here, we demonstrate that ten cats that received a transfusion of blood from aviremic provirus carriers developed active FeLV infections, some with a progressive outcome and the development of fatal FeLV-associated disease. The infection outcome, disease spectrum and evolution into FeLV-C in one cat mirrored those of natural infection. Two cats developed persistent antigenemia; six cats were transiently antigenemic. Reactivation of infection occurred in some cats. One recipient developed non-regenerative anemia associated with FeLV-C, and four others developed a T-cell lymphoma, one with secondary lymphoblastic leukemia. Five of the ten recipient cats received provirus-positive aviremic blood, whereas the other five received provirus- and viral RNA-positive but aviremic blood. Notably, the cats that received blood containing only proviral DNA exhibited a later onset but graver outcome of FeLV infection than the cats that were transfused with blood containing proviral DNA and viral RNA. Leukocyte counts and cytokine analyses indicated that the immune system of the latter cats reacted quicker and more efficiently. Conclusions Our results underline the biological and epidemiological relevance of FeLV provirus carriers and the risk of inadvertent FeLV transmission via blood transfusion and demonstrate the replication capacity of proviral DNA if uncontrolled by the immune system. Our results have implications not only for veterinary medicine, such as the requirement for testing blood donors and blood products for FeLV provirus by sensitive polymerase chain reaction, but are also of general interest by revealing the importance of latent retroviral DNA in infected hosts. When aiming to eliminate a retroviral infection from a population, provirus carriers must be considered. Electronic supplementary material The online version of this article (doi:10.1186/s12977-015-0231-z) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Stefanie Nesina
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. .,Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - A Katrin Helfer-Hungerbuehler
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. .,Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Barbara Riond
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Felicitas S Boretti
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Barbara Willi
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. .,Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Marina L Meli
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. .,Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Paula Grest
- Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. .,Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| |
Collapse
|
40
|
Quantification of southern rice black streaked dwarf virus and rice black streaked dwarf virus in the organs of their vector and nonvector insect over time. Virus Res 2015; 208:146-55. [PMID: 26116274 DOI: 10.1016/j.virusres.2015.06.015] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 06/15/2015] [Accepted: 06/16/2015] [Indexed: 11/21/2022]
Abstract
Southern rice black streaked dwarf virus (SRBSDV) and rice black streaked dwarf virus (RBSDV) are serious rice-infecting reoviruses, which are transmitted by different planthoppers in a persistent propagative manner. In this study, we quantitatively compared the spatial distribution of SRBSDV and RBSDV contents over time in their vector and nonvector insects using real time-PCR. Genome equivalent copies (GEC) were assessed every 2 days from 0 to 14 days after a 3-days acquisition access period (AAP) on infected plants. Results revealed 293.2±21.6 to 404.1±46.4 SRBSDV GEC/ng total RNA in whole body of white-backed planthopper (WBPH, Sogatella furcifera) at day 0 and 12 and 513.5±88.4 to 816.8±110.7 RBSDV GEC/ng total RNA in the whole body of small brown planthopper (SBPH, Laodelphax striatellus) at day 0 and 14, respectively, after 3-days AAP. Highest GEC of both viruses were found in the gut of their respective vectors. Although SRBSDV was detected in the gut of SBPH, it did not spread into the hemolymph or other organs. After an 8-day latent period, the transmission efficiency of SRBSDV and RBSDV by their respective vectors was significantly positively correlated with GEC in the salivary gland (r(2)=0.7808, P=0.0036 and r(2)=0.9351, P<0.0001, respectively, at α=0.05). Together, these results confirm that accumulation of >200 SRBSDV or RBSDV GEC/ng total RNA in the gut of vector, indicated threshold for further spread and the virus content in the salivary gland was significantly correlated with transmission efficiency by their respective vectors.
Collapse
|
41
|
No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus. Vaccine 2015; 33:1578-85. [PMID: 25698488 DOI: 10.1016/j.vaccine.2015.02.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2014] [Accepted: 02/04/2015] [Indexed: 11/22/2022]
Abstract
Therapeutic vaccinations have a potential application in infections where no curative treatment is available. In contrast to HIV, efficacious vaccines for a cat retrovirus, feline leukemia virus (FeLV), are commercially available. However, the infection is still prevalent, and no effective treatment of the infection is known. By vaccinating persistently FeLV-infected cats and presenting FeLV antigens to the immune system of the host, e.g., in the form of recombinant and/or adjuvanted antigens, we intended to shift the balance toward an advantage of the host so that persistent infection could be overcome by the infected cat. Two commercially available FeLV vaccines efficacious in protecting naïve cats from FeLV infection were tested in six experimentally and persistently FeLV-infected cats: first, a canarypox-vectored vaccine, and second, an adjuvanted, recombinant envelope vaccine was repeatedly administered with the aim to stimulate the immune system. No beneficial effects on p27 antigen and plasma viral RNA loads, anti-FeLV antibodies, or life expectancy of the cats were detected. The cats were unable to overcome or decrease viremia. Some cats developed antibodies to FeLV antigens although not protective. Thus, we cannot recommend vaccinating persistently FeLV-infected cats as a means of improving their FeLV status, quality of life or life expectancy. We suggest testing of all cats for FeLV infection prior to FeLV vaccination.
Collapse
|